Wei Leong Chew

Dr. Wei Leong Chew is GIS Fellow at the Genome Institute of Singapore, A * STAR. His lab develops technologies for making pinpoint changes in the human genome. His work contributed to the first demonstrations of postnatal disease gene correction and transcriptional activation with CRISPR-Cas9. He identified the immunogenic determinants on AAV-CRISPR-Cas9, providing a first insight into the safety profile of CRISPR therapeutics. He co-directs the Molecular Therapeutics Programme - the first DNA and RNA -targeting therapeutics development center in Southeast Asia. Dr. Chew graduated from Duke University for his B.S., and obtained his Ph.D. with Prof. George Church at Harvard Medical School.

Companies

• Adjunct Assistant Professor National University of Singapore (2021)
• Associate Director Genome Institute of Singapore (2021)
• Senior Research Scientist Genome Institute of Singapore (2019)
• Principal Investigator Genome Institute of Singapore (2016)
• GIS Fellow Genome Institute of Singapore (2016 — 2019)
• Graduate student Harvard University (2010 — 2016)
• Research assistant Duke-NUS Graduate Medical School (2009 — 2010)

Education

• Doctor of Philosophy (PhD) Harvard University (2010 — 2016)
• Bachelor of Science (B.S.) Duke University (2006 — 2009)
• A levels Raffles Junior College